AskBio Advances Gene Therapy Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 AskBio Inc., a leading gene therapy company wholly owned by Bayer AG, has announced a significant milestone in its Phase 1/Phase 2 LION-CS101 clinical trial for the investigational gene…
Cronton College Students Explore STEM Careers at Bachem UK Science, Technology, Engineering, and Mathematics (STEM) are pivotal to the development and innovation in various sectors, including healthcare, technology, and environmental sustainability. STEM careers are more crucial than ever, offering exciting…
WACKER Replaces Coal with Biogenic Carbon for Climate-Neutral Silicon Production WACKER, a global leader in the production of high-purity silicones and silicon-based products, is embarking on an important sustainability milestone by replacing fossil coal with biogenic carbon in its silicon…
Aerospace & Life Sciences Testing, Inspection, and Certification Market Overview has been added to ResearchAndMarkets.com’s offering. The global market for Aerospace & Life Sciences Testing, Inspection, and Certification (TIC) services is expected to grow significantly in the coming years. Valued at approximately…
QIAGEN Receives U.S. FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel QIAGEN has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, marking a significant milestone in the company’s…
ENCell’s EN001 Receives FDA Orphan Drug Designation for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, has announced that its investigational drug, EN001, has been granted Orphan Drug Designation (ODD) by the U.S. Food and…
Promega Sues Aobious for Patent Infringement Over Furimazine Substrates Promega Corporation, a global leader in biotechnology tools, announced that it has filed a patent infringement lawsuit against Aobious, Inc. The lawsuit, filed in the U.S. District Court for the District…
TRIMTECH Therapeutics Secures $31M in Seed Funding to Advance Targeted Protein Degradation Treatments for Neurodegenerative Diseases TRIMTECH Therapeutics, a biotech company focused on developing therapies using targeted protein degradation (TPD) for neurodegenerative diseases, has announced the successful completion of its…
Supreme Group Acquires Kadiko to Strengthen Digital and Creative Capabilities in Healthcare and Life Sciences Supreme Group, a leading platform focused on driving innovation in healthcare and life sciences marketing and communications, has announced the acquisition of Kadiko, a digital-first…
Osmo Launches Generation: The World’s First AI-Powered Fragrance House Osmo, the pioneer in digitizing scent, has unveiled Generation, an innovative fragrance house powered by Olfactory Intelligence (OI). This groundbreaking technology, which transforms data into scent, offers brands and creators an…
Ascribe Bio’s Phytalix® Breakthrough in Bacterial Leaf Blight (BLB) Control: A Game-Changer for Rice Farmers Introduction: A Breakthrough in Crop Protection Ascribe Bio, an innovator in the field of natural crop protection, has announced the success of its flagship product,…
Groundbreaking Discovery: Membrane Lipid Replacement Boosts Energy and Slows Aging Nutritional Therapeutics: Restoring Cell Membranes Boosts Energy, Reduces Fatigue, and Slows Aging Nutritional Therapeutics: A pioneering article in Nature Cell Science introduces a revolutionary approach to combating aging and fatigue…